Company Filing History:
Years Active: 1982-1987
Title: The Innovative Contributions of Cyril Boroda
Introduction
Cyril Boroda is a notable inventor based in London, GB. He has made significant contributions to the field of medicine, particularly in the development of preparations for percutaneous administration of nitroglycerine. With a total of 2 patents to his name, Boroda's work has the potential to enhance the treatment of conditions such as angina.
Latest Patents
Cyril Boroda's latest patents focus on a preparation for percutaneous administration of nitroglycerine. This preparation comprises nitroglycerine incorporated in a cream base, with a concentration of no less than about 0.05% by weight based on the total weight of the preparation. The composition may also include other medicaments, which benefit from enhanced bioavailability due to the presence of nitroglycerine. The preparation is designed to effectively combat angina by utilizing an appropriate amount of nitroglycerine or additional medicaments that are active against the condition. Furthermore, the formulation may contain hydroxyalkylcellulose, which, in combination with a waxy component such as a higher aliphatic alcohol, provides a prolonged release effect. This innovative preparation offers advantages in bioavailability compared to prior uniphasic ointments.
Career Highlights
Cyril Boroda is associated with Euro-Celtique S.A., where he continues to develop his innovative ideas. His work in this company has allowed him to focus on creating effective medical solutions that can improve patient outcomes.
Collaborations
Cyril has collaborated with notable coworkers, including Stewart Thomas Leslie and Alan Rhodes. Their combined expertise contributes to the advancement of their projects and the successful development of new medical preparations.
Conclusion
Cyril Boroda's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving healthcare solutions. His work on nitroglycerine preparations showcases the potential for enhanced treatment options for patients suffering from angina.